Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease
Shanshan Li, Aiqing Xie, Hui Li, et al.
Journal of Controlled Release (2019) Vol. 316, pp. 66-78
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Biological drug and drug delivery-mediated immunotherapy
Qingqing Xiao, Xiaotong Li, Yi Li, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 4, pp. 941-960
Open Access | Times Cited: 157
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
Chengxin Shi, Jianati Dawulieti, Feiyu Shi, et al.
Science Advances (2022) Vol. 8, Iss. 4
Open Access | Times Cited: 153
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy
Cui Liu, Xiangji Yan, Yujie Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 147
Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization
Xinyuan Yang, Jiali Yang, Zihan Ye, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4041-4058
Closed Access | Times Cited: 112
Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Yuji Pu, Fan Xi, Zhuangzhuang Zhang, et al.
Journal of Controlled Release (2022) Vol. 354, pp. 1-18
Closed Access | Times Cited: 77
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
Arianna Rinaldi, Riccardo Caraffi, Maria Vittoria Grazioli, et al.
Polymers (2022) Vol. 14, Iss. 4, pp. 687-687
Open Access | Times Cited: 75
Surface design of nanocarriers: Key to more efficient oral drug delivery systems
Helen Spleis, Matthias Sandmeier, Victor Claus, et al.
Advances in Colloid and Interface Science (2023) Vol. 313, pp. 102848-102848
Open Access | Times Cited: 56
Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species
Cong Zhang, Qingrong Li, Jianghao Xing, et al.
Acta Biomaterialia (2024) Vol. 177, pp. 347-360
Closed Access | Times Cited: 29
Nano-targeted delivery system: a promising strategy of anthocyanin encapsulation for treating intestinal inflammation
Hao Zhong, Xin Luo, Abdullah, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-22
Closed Access | Times Cited: 2
Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases
Chenwen Li, Lanlan Li, Sheng Chen, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 87
Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases
Cuiyun Shen, Luqing Zhao, Xueying Du, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 1419-1430
Closed Access | Times Cited: 63
Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel disease
Yi Chen, Mingju Shui, Qin Yuan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 510-540
Closed Access | Times Cited: 36
Microneedle-mediated delivery of Ziconotide-loaded liposomes fused with exosomes for analgesia
Kaichao Song, Yumei Hao, Xiaochuan Tan, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 448-462
Closed Access | Times Cited: 30
Gram-scale preparation of quercetin supramolecular nanoribbons for intestinal inflammatory diseases by oral administration
Wei Sun, Yingxuan Chen, Liang Wang, et al.
Biomaterials (2023) Vol. 295, pp. 122039-122039
Closed Access | Times Cited: 28
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers
Patrizia Garbati, Cristiana Picco, Raffaella Magrassi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 431-431
Open Access | Times Cited: 15
Self-assembly strategies of organic small-molecule photosensitizers for photodynamic therapy
Xiaohui Xiong, Jingyuan Liu, Lei Wu, et al.
Coordination Chemistry Reviews (2024) Vol. 510, pp. 215863-215863
Closed Access | Times Cited: 15
Stimulus-Responsive Drug Delivery Nanoplatforms for Inflammatory Bowel Disease Therapy
Long Jiang, Xiaoya Liang, Zuojin Ao, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 12
Orally Administrated Precision Nanomedicine for Restoring the Intestinal Barrier and Alleviating Inflammation in Treatment of Inflammatory Bowel Disease
Ding Wang, Qi Jiang, Pei‐Rong Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access | Times Cited: 1
Reactive Oxygen Species Activatable Heterodimeric Prodrug as Tumor-Selective Nanotheranostics
Meijuan Jiang, Jing Mu, Orit Jacobson, et al.
ACS Nano (2020) Vol. 14, Iss. 12, pp. 16875-16886
Closed Access | Times Cited: 64
Sodium para-aminosalicylic acid inhibits manganese-induced NLRP3 inflammasome-dependent pyroptosis by inhibiting NF-κB pathway activation and oxidative stress
Dongjie Peng, Junyan Li, Yue Deng, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 62
pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis
Haiting Xu, Ruifeng Luo, Lingling Dong, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 39, pp. 102461-102461
Closed Access | Times Cited: 50
Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD
Olga Hartwig, Maryam A. Shetab Boushehri, Karim S. Shalaby, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113828-113828
Closed Access | Times Cited: 48
A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment
Runze Zhao, Xiaoyue Ning, Mengqi Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 22, pp. 25080-25092
Closed Access | Times Cited: 31
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
Shiyun Xian, Jiabin Zhu, Yuchen Wang, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 17
Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment
Jian Gao, Jiannan Li, Zengyou Luo, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2921-2949
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top